TRACON Pharmaceuticals
Stock Forecast, Prediction & Price Target
TRACON Pharmaceuticals Financial Estimates
TRACON Pharmaceuticals Revenue Estimates
TRACON Pharmaceuticals EBITDA Estimates
TRACON Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $346K N/A | $0 -100% | $12.04M 0% | Avg: $1.75M Low: $1.75M High: $1.75M avg. -85.47% | Avg: $29.63M Low: $29.63M High: $29.63M avg. 1593.62% | Avg: $76.24M Low: $76.24M High: $76.24M avg. 157.24% | Avg: $130.34M Low: $130.34M High: $130.34M avg. 70.94% |
Net Income
% change YoY
| $-28.72M N/A | $-29.31M -2.03% | $-3.58M 87.75% | Avg: $-21.49M Low: $-185.34M High: $-56.65M avg. -499.08% | Avg: $-5.47M Low: $-27.83M High: $31.76M avg. 74.51% | Avg: $29.14M Low: $29.14M High: $29.14M avg. 631.96% | Avg: $126.39M Low: $126.39M High: $126.39M avg. 333.70% |
EBITDA
% change YoY
| $-28.34M N/A | $-27.89M 1.59% | $-6.88M 75.32% | Avg: $499.96K Low: $499.96K High: $499.96K avg. 107.26% | Avg: $8.46M Low: $8.46M High: $8.46M avg. 1593.63% | Avg: $21.78M Low: $21.78M High: $21.78M avg. 157.24% | Avg: $37.23M Low: $37.23M High: $37.23M avg. 70.94% |
EPS
% change YoY
| -$1.67 N/A | -$1.4 16.16% | -$2.2 -57.14% | Avg: -$3.7 Low: -$5.66 High: -$1.73 avg. -67.95% | Avg: $0.06 Low: -$0.85 High: $0.97 avg. 101.62% | Avg: $0.89 Low: $0.89 High: $0.89 avg. 1383.33% | Avg: $3.86 Low: $3.86 High: $3.86 avg. 333.70% |
Operating Expenses
% change YoY
| $28.69M N/A | $27.89M -2.78% | $18.92M -32.13% | Avg: $18.99M Low: $18.99M High: $18.99M avg. 0.34% | Avg: $321.68M Low: $321.68M High: $321.68M avg. 1593.62% | Avg: $827.52M Low: $827.52M High: $827.52M avg. 157.24% | Avg: $1.41B Low: $1.41B High: $1.41B avg. 70.94% |
FAQ
What is TRACON Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 135.27% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -185.34M, average is -21.49M and high is -56.65M.
What is TRACON Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 434.08% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $1.75M, average is $1.75M and high is $1.75M.
What is TRACON Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 437.67% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$5.66, average is -$3.7 and high is $-1.73.